Black Bird Biotech, Inc.
BBBT · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Market Cap | $0 | $4 | $6 | $17 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $0 | $0 | $1 |
| Enterprise Value | $1 | $4 | $6 | $18 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -21% | 81.3% | 224.1% | – |
| Gross Profit | -$0 | $0 | $0 | -$0 |
| % Margin | -67.7% | 18.8% | 51% | -0.2% |
| EBITDA | -$1 | -$1 | -$1 | -$0 |
| % Margin | -1,452.5% | -1,355.9% | -1,187.9% | -823.7% |
| Net Income | -$2 | -$2 | -$1 | -$0 |
| % Margin | -2,009.1% | -1,734% | -1,200.6% | -920.8% |
| EPS Diluted | -0.005 | -0.009 | -0.006 | -0.001 |
| % Growth | 46.2% | -63.2% | -307.1% | – |
| Operating Cash Flow | -$1 | -$1 | -$1 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | $0 |
| Free Cash Flow | -$1 | -$1 | -$1 | -$0 |